EGFR and cancer: The overexpression and activation of the ERBB family are closely related to the clinicopathological characteristics and prognosis of various cancers, including melanoma, lung cancer, gastric cancer, breast cancer, etc. (Bittoni et al., 2015; Oudard et al., 2015).